EkoSonic Endovascular System in China RWS(ANTEATER)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days).
• The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
• Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Locations
Other Locations
China
The first Affiliated Hospital, Sun Yat-sen University
RECRUITING
Guangzhou
Contact Information
Primary
Guangqi Chang, Doctor
changgq@mail.sysu.edu.cn
020-87755766
Backup
Cheng Hong, Doctor
gyfyyhc@126.com
020-81568636
Time Frame
Start Date: 2026-08-30
Estimated Completion Date: 2029-05-30
Participants
Target number of participants: 30
Treatments
Single group observational study
To collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation